G25.71

Clinical Causes: Use of neuroleptic medications prescribed for psychiatric conditions such as schizophrenia or bipolar disorder. Certain antidepressants, especially selective serotonin reuptake inhibitors (SSRIs). Other medications like metoclopramide, which is used for gastrointestinal issues. Prolonged use or sudden discontinuation of these medications may increase the risk. Individual susceptibility based on genetics or existing neurological conditions.

Key Symptoms: A strong feeling of inner restlessness and an urge to move. Fidgeting, pacing, or constant shifting of position. Inability to sit still for extended periods. Anxiety or heightened tension related to the movement sensations. Sometimes accompanied by tremors or involuntary movements. Discomfort that may worsen during periods of inactivity, improving with movement.

Diagnosis Path: Diagnosis primarily involves a clinical assessment by a healthcare provider, including a detailed review of the patient's medical history and medication usage. No specific laboratory test exists for akathisia. The clinician observes the patient’s movements and evaluates the timing and correlation with medication use. Differential diagnosis is essential to rule out other movement disorders like Parkinson's disease or side effects of different medications.

Treatment Protocols: Adjusting or lowering the dose of the causative medication under medical supervision. Switching to an alternative medication with a lower risk of akathisia. Adding medications such as beta-blockers (e.g., propranolol) or benzodiazepines to alleviate symptoms. Implementing non-pharmacological approaches like counseling and relaxation techniques. Regular monitoring to detect early signs of movement disturbances and modify treatment accordingly.